anaphylaxis

COPENHAGEN, Denmark — September 17, 2026 Orbis Medicines announced a strategic collaboration and license agreement with Novo Nordisk to...

WARREN, N.J. — September 17, 2026 Aquestive Therapeutics announced the resubmission of its New Drug Application (NDA) to the...

TEL AVIV, Israel — September 14, 2026 Nasus Pharma Ltd. announced that the U.S. Food and Drug Administration (FDA)...

SCHLIEREN/ZURICH, Switzerland, May 19, 2026 Mabylon AG announced positive preliminary Phase Ia clinical data for its lead investigational therapy...

San Diego, U.S. | April 15, 2026 ARS Pharmaceuticals has achieved a major regulatory milestone with Health Canada approval...

SAN DIEGO, March 27, 2026 ARS Pharmaceuticals has received U.S. FDA approval to update the labeling of neffy® (epinephrine...